10-Q Filing

MERCK & CO., INC. CIK: 310158 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0000310158-22-000011`
Period End Date	20220331
Filing Date	20220505
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	mrk-20220331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 40 Cash Flow Statement 64 Comprehensive Income 12

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$95.00M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$62.00M	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$2.19B	USD	Point-in-time
Inventories classified in Other assets	`InventoryNoncurrent`	$2.50B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.56B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$18.50B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.10B	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$18.19B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$372.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	-	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.50	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	6.50B	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $95 in 2022 and $62 in 2021)	`AccountsReceivableNetCurrent`	$9.83B	USD	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $95 in 2022 and $62 in 2021)	`AccountsReceivableNetCurrent`	$9.23B	USD	Point-in-time
Inventories (excludes inventories of $2,495 in 2022 and $2,194 in 2021 classified in Other assets - see Note 7)	`InventoryNet`	$5.77B	USD	Point-in-time
Inventories (excludes inventories of $2,495 in 2022 and $2,194 in 2021 classified in Other assets - see Note 7)	`InventoryNet`	$5.95B	USD	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Common stock, issued (in shares)	`CommonStockSharesIssued`	3.58B	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	1.05B	shares	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$6.99B	USD	Point-in-time
Other current assets	`DeferredIncomeTaxesAndOtherAssetsCurrent`	$6.65B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	1.05B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$31.18B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$30.27B	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$316.00M	USD	Point-in-time
Investments	`MarketableSecuritiesNoncurrent`	$370.00M	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,498 in 2022 and $18,192 in 2021	`PropertyPlantAndEquipmentNet`	$19.75B	USD	Point-in-time
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,498 in 2022 and $18,192 in 2021	`PropertyPlantAndEquipmentNet`	$19.28B	USD	Point-in-time
Goodwill	`Goodwill`	$21.26B	USD	Point-in-time
Goodwill	`Goodwill`	$21.26B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$23.02B	USD	Point-in-time
Other Intangibles, Net	`IntangibleAssetsNetExcludingGoodwill`	$22.93B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$11.14B	USD	Point-in-time
Other Assets	`DeferredIncomeTaxesAndOtherAssetsNoncurrent`	$11.58B	USD	Point-in-time
Total Assets	`Assets`	$106.67B	USD	Point-in-time
Total Assets	`Assets`	$105.69B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$2.41B	USD	Point-in-time
Loans payable and current portion of long-term debt	`DebtCurrent`	$1.21B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$4.61B	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$3.71B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$14.05B	USD	Point-in-time
Accrued and other current liabilities	`OtherLiabilitiesCurrent`	$13.86B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.57B	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$1.22B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.77B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$1.77B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$22.32B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$23.87B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$30.59B	USD	Point-in-time
Long-Term Debt	`LongTermDebtNoncurrent`	$30.69B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.44B	USD	Point-in-time
Deferred Income Taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.07B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$9.43B	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$9.74B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021	`CommonStockValue`	$1.79B	USD	Point-in-time
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2022 and 2021	`CommonStockValue`	$1.79B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$44.24B	USD	Point-in-time
Other paid-in capital	`AdditionalPaidInCapitalCommonStock`	$44.27B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$53.70B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.25B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.37B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.43B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$97.95B	USD	Point-in-time
Stockholders' equity before deduction for treasury stock	`StockholdersEquityBeforeTreasuryStock`	$95.29B	USD	Point-in-time
Less treasury stock, at cost: 1,048,727,225 shares in 2022 and 1,049,499,023 shares in 2021	`TreasuryStockCommonValue`	$57.06B	USD	Point-in-time
Less treasury stock, at cost: 1,048,727,225 shares in 2022 and 1,049,499,023 shares in 2021	`TreasuryStockCommonValue`	$57.11B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$40.88B	USD	Point-in-time
Total Merck & Co., Inc. stockholders equity	`StockholdersEquity`	$38.18B	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$73.00M	USD	Point-in-time
Noncontrolling Interests	`MinorityInterest`	$70.00M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$27.04B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$40.95B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.26B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.40B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$105.69B	USD	Point-in-time
Liabilities and Equity	`LiabilitiesAndStockholdersEquity`	$106.67B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$15.90B	USD	1 Quarter
Sales	`Revenues`	$10.63B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$5.38B	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$3.20B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.32B	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.19B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.41B	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.58B	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$53.00M	USD	1 Quarter
Restructuring costs	`RestructuringCharges`	$297.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-708.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$455.00M	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$7.64B	USD	1 Quarter
Total Costs, Expenses and Other	`CostsExpensesAndOther`	$11.04B	USD	1 Quarter
Income from Continuing Operations Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.86B	USD	1 Quarter
Income from Continuing Operations Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.99B	USD	1 Quarter
Taxes on Income from Continuing Operations	`IncomeTaxExpenseBenefit`	$554.00M	USD	1 Quarter
Taxes on Income from Continuing Operations	`IncomeTaxExpenseBenefit`	$238.00M	USD	1 Quarter
Net Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$4.31B	USD	1 Quarter
Net Income from Continuing Operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$2.75B	USD	1 Quarter
Less: Net (Loss) Income Attributable to Noncontrolling Interests	`IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity`	$4.00M	USD	1 Quarter
Less: Net (Loss) Income Attributable to Noncontrolling Interests	`IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity`	$-3.00M	USD	1 Quarter
Net Income from Continuing Operations Attributable to Merck & Co., Inc.	`IncomeLossFromContinuingOperations`	$2.75B	USD	1 Quarter
Net Income from Continuing Operations Attributable to Merck & Co., Inc.	`IncomeLossFromContinuingOperations`	$4.31B	USD	1 Quarter
Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	-	USD	1 Quarter
Income from Discontinued Operations, Net of Taxes and Amounts Attributable to Noncontrolling Interests	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$434.00M	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.18B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$4.31B	USD	1 Quarter
Income from Continuing Operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.08	USD	1 Quarter
Income from Continuing Operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.70	USD	1 Quarter
Income from Discontinued Operations (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Income from Discontinued Operations (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	$0.17	USD	1 Quarter
Net Income (in dollars per share)	`EarningsPerShareBasic`	$1.26	USD	1 Quarter
Net Income (in dollars per share)	`EarningsPerShareBasic`	$1.70	USD	1 Quarter
Income from Continuing Operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.70	USD	1 Quarter
Income from Continuing Operations (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.08	USD	1 Quarter
Income from Discontinued Operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Income from Discontinued Operations (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$0.17	USD	1 Quarter
Net Income (in dollars per share)	`EarningsPerShareDiluted`	$1.70	USD	1 Quarter
Net Income (in dollars per share)	`EarningsPerShareDiluted`	$1.25	USD	1 Quarter

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCashAndCashEquivalents`	$103.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$71.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$42.00M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$58.00M	USD	Point-in-time
Net income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$4.31B	USD	1 Quarter
Net income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$2.75B	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$699.00M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$514.00M	USD	1 Quarter
Depreciation	`Depreciation`	$378.00M	USD	1 Quarter
Depreciation	`Depreciation`	$421.00M	USD	1 Quarter
Loss (income) from investments in equity securities, net	`EquitySecuritiesFvNiGainLoss`	$574.00M	USD	1 Quarter
Loss (income) from investments in equity securities, net	`EquitySecuritiesFvNiGainLoss`	$-708.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-338.00M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$18.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$120.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$111.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-236.00M	USD	1 Quarter
Other	`OtherNoncashIncomeExpense`	$-143.00M	USD	1 Quarter
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$2.19B	USD	1 Quarter
Net changes in assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$1.30B	USD	1 Quarter
Net Cash Provided by Operating Activities of Continuing Operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$4.76B	USD	1 Quarter
Net Cash Provided by Operating Activities of Continuing Operations	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$1.24B	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$984.00M	USD	1 Quarter
Capital expenditures	`PaymentsToAcquireProductiveAssets`	$1.08B	USD	1 Quarter
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$372.00M	USD	1 Quarter
Purchases of securities and other investments	`PaymentsToAcquireMarketableSecurities`	$1.00M	USD	1 Quarter
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$1.00M	USD	1 Quarter
Proceeds from sales of securities and other investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$386.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-11.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-182.00M	USD	1 Quarter
Net Cash Used in Investing Activities of Continuing Operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.17B	USD	1 Quarter
Net Cash Used in Investing Activities of Continuing Operations	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-686.00M	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$788.00M	USD	1 Quarter
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	1 Quarter
Payments on debt	`RepaymentsOfLongTermDebt`	$1.25B	USD	1 Quarter
Payments on debt	`RepaymentsOfLongTermDebt`	$1.15B	USD	1 Quarter
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$1.75B	USD	1 Quarter
Dividends paid to stockholders	`PaymentsOfDividendsCommonStock`	$1.65B	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$9.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$12.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-97.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-103.00M	USD	1 Quarter
Net Cash Used in Financing Activities of Continuing Operations	`NetCashProvidedByUsedInFinancingActivities`	$-3.09B	USD	1 Quarter
Net Cash Used in Financing Activities of Continuing Operations	`NetCashProvidedByUsedInFinancingActivities`	$-2.10B	USD	1 Quarter
Net cash provided by operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$551.00M	USD	1 Quarter
Net cash provided by operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	-	USD	1 Quarter
Net cash used in investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-52.00M	USD	1 Quarter
Net Cash Flows Provided by Discontinued Operations	`NetCashProvidedByUsedInDiscontinuedOperations`	$499.00M	USD	1 Quarter
Net Cash Flows Provided by Discontinued Operations	`NetCashProvidedByUsedInDiscontinuedOperations`	-	USD	1 Quarter
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-55.00M	USD	1 Quarter
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-97.00M	USD	1 Quarter
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$447.00M	USD	1 Quarter
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.14B	USD	1 Quarter
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.88B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.61B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.16B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at Beginning of Year (includes restricted cash of $71 and $103 at January 1, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.17B	USD	Point-in-time
Less: Cash and cash equivalents related to discontinued operations	`DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents`	-	USD	Point-in-time
Less: Cash and cash equivalents related to discontinued operations	`DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents`	$141.00M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $58 and $42 at March 31, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.88B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $58 and $42 at March 31, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.61B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $58 and $42 at March 31, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.16B	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash at End of Period (includes restricted cash of $58 and $42 at March 31, 2022 and 2021, respectively, included in Other current assets)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$8.17B	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$3.18B	USD	1 Quarter
Net Income Attributable to Merck & Co., Inc.	`NetIncomeLoss`	$4.31B	USD	1 Quarter
Net unrealized gain on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$230.00M	USD	1 Quarter
Net unrealized gain on derivatives, net of reclassifications	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent`	$63.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-32.00M	USD	1 Quarter
Benefit plan net gain and prior service credit, net of amortization	`OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent`	$-81.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-35.00M	USD	1 Quarter
Cumulative translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-299.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$60.00M	USD	1 Quarter
Other comprehensive income (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.00M	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$4.37B	USD	1 Quarter
Comprehensive Income Attributable to Merck & Co., Inc.	`ComprehensiveIncomeNetOfTax`	$3.19B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.